Cargando…
Emerging Molecular Targets for Anti-Epileptogenic and Epilepsy Modifying Drugs
The pharmacological treatment of epilepsy is purely symptomatic. Despite many decades of intensive research, causal treatment of this common neurologic disorder is still unavailable. Nevertheless, it is expected that advances in modern neuroscience and molecular biology tools, as well as improved an...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9917847/ https://www.ncbi.nlm.nih.gov/pubmed/36769250 http://dx.doi.org/10.3390/ijms24032928 |